Travere Therapeutics, Inc. (TVTX) scores 38 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $25.57, representing a 5% premium to fair value.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.